BioRestorative Therapies Inc Ordinary Shares BRTX 深 沪
等待开盘 08-14 09:30:00 美东时间
1.50
+0.030
+2.04%
华盛通- 最 高1.52
- 今 开1.41
- 成交量 2.63万股
- 最 低 1.41
- 昨 收 1.47
- 总市值 1125.72万
- 52周最高 2.55
- 市盈率 静 --
- 换手率 0.35%
- 52周最低 1.21
- 委 比 11.11%
- 总股本 750.48万
- 历史最高 8.90
- 量 比 0.99
- 振 幅 7.48%
- 历史最低 1.03
- 每 手 1
- 风险率 0.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioRestorative Therapies Issues Non-Material Press Release
BioRestorative Therapies ( ($BRTX) ) has issued an announcement. BioRestorative...
08-13 05:18
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
**BioRestorative Therapies, Inc. 2025年第二季度财务和业务摘要** BioRestorative Therapies, Inc.（纳斯达克股票代码：BRTX）是一家专注于干细胞疗法和产品的再生医学创新公司。公司公布了截至2025年6月30日的第二季度财务和业务更新。 - **财务亮点**：第二季度收入约为30.3万美元，较2024年同期增长240%，主要来自与Cartessa Aesthetics的美容生物制剂销售。净亏损为270万美元，较2024年同期400万美元有所改善。公司现金储备为740万美元，无债务。 - **近期进展**： - ** tariff 影响**：确认无重大关税风险。 - **股票回购**：批准200万美元股票回购计划。 - **高管加入**：Sandy Lipkins加入团队，负责战略联盟和许可协议。 - **临床数据**：BRTX-100在脊椎退行性疾病中显示出显著疗效，超过50%的功能改善。 - *...
08-12 20:05
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
Earnings Outlook For BioRestorative Therapies
BioRestorative Therapies (NASDAQ:BRTX) is gearing up to announce its quarterly ...
08-12 03:04
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
<p>BioRestorative Therapies, Inc. (NASDAQ: BRTX), a clinical stage regenerative medicine company specializing in stem cell-based therapies, announced it will release its second quarter 2025 financial results after market close on August 12, 2025. A conference call to discuss the results will follow at 4:30 p.m. ET. The call details include domestic toll-free number 1-888-506-0062, international number 1-973-528-0011, and access code 436077. Addit...
08-05 20:30
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
BioRestorative Therapies, Inc. (BRTX) announced that its CEO, Lance Alstodt, will be interviewed on the Benzinga All-Access Show on June 18, 2025, at 10:50 a.m. ET. The company specializes in stem cell-based therapies, focusing on three clinical programs: BRTX-100 for disc/spine disease, ThermoStem® for metabolic disorders, and BioCosmeceuticals for aesthetic treatments. BRTX-100 is in Phase 2 trials for chronic lower back pain, while ThermoStem®...
06-18 13:35
【TradingKey財經早餐】川普威脅打擊伊朗，油價大漲5%，特斯拉跌4%，光伏股Sunrun暴跌40%；參議院通過穩定幣法案
TradingKey - 6月17日週二，川普威脅軍事介入以伊衝突並呼籲伊朗無條件投降，油價飆升5%，美股全線回落，特斯拉跌4%，受太陽能稅收優惠將逐步取消影響的光伏股Sunrun暴跌40%，腦機接口概念股腦再生科技漲30%。美媒報道稱，川普正越來越有意動用美國軍事資產空襲伊朗核設施；若伊朗作出重大讓步，仍對外交手段保持開放態度。
06-18 00:58
BioRestorative Therapies announces share repurchase program; shares gain over 8%
BioRestorative Therapies (NASDAQ:BRTX) announced on Tuesday that its board of directors has authorized a stock repurchase program to repurchase up to $2 million of its outstanding common stock through...
06-17 21:32
BioRestorative Therapies Announces $2M Stock Repurchase Program
BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that its Board
06-17 21:25
BioRestorative Announces Share Repurchase Program
BioRestorative Therapies, Inc. (BRTX) announced a $2 million stock repurchase program through June 16, 2026, reflecting confidence in its clinical pipeline and future growth. CEO Lance Alstodt cited the company's strong science and assets, stating current share price undervalues its intrinsic worth. Repurchases may occur via open market or private transactions, with management discretion based on market conditions. The program highlights BRTX's f...
06-17 13:25
